Most recent update: Thursday, January 23, 2020 - 09:45

Bariatric News - Cookies & privacy policy

You are here


Type 2 diabetes Revita System study launches in US

A same-day procedural therapy to improve glucose control for Type 2 diabetes patients will be investigated in a pilot study at The University of Texas Health Science Center at Houston (UTHealth). Drs Absalon D Gutierrez and Nirav C Thosani are among the first physician-researchers in the country to assess the safety and effectiveness of The Revita System, designed to help improve blood sugar levels without the need for additional medications.

Banded sleeve gastrectomy vs sleeve gastrectomy

Later this year, researchers in Australia will publish the first data from a study that is comparing sleeve gastrectomy vs sleeve gastrectomy with a MiniMizer Ring (Bariatric Solutions) in 400 obese patients. Bariatric News talked to the lead investigator, Dr Chris Couch from the Perth Obesity Surgery clinic, about the causes of weight regain after surgery and the aims of the study.

Study to investigate insufficient weight loss and weight regain

A team of researchers at seven institutions across the US is working to find out why some patients who undergo weight loss surgery do not lose the weight they expect or they regain weight. Dr Kristine Steffen, associate professor of pharmaceutical sciences in the North Dakota State University (NDSU) School of Pharmacy is receiving a US$3.7 million, five-year grant award for a study that examines how biological and behavioural factors interact in determining the success of bariatric surgery.

neoSurgical begins gastric bypass neoclose study

neoSurgical has that it has begun a Postmarket Surveillance Study of its FDA-cleared device, neoClose, at University of Texas Health Sciences Center at Houston, TX. The randomised study will compare neoClose against the standard of care for closure in a bariatric surgery gastric bypass population of 70 adults aged 18-70 years with BMI>35. Principal investigators include: Drs Erik B Wilson, Professor of Surgery; Peter A Walker, Assistant Professor of Surgery and Shinil K Shah, Assistant Professor of Surgery.

Drug that mimics bypass assessed for T2DM treatment

BioKier has initiated a randomised, double-blind, placebo-controlled, parallel dose group study to evaluate changes in fasting glucose after a four-week treatment period with L-glutamine or sodium butyrate administered by rectal suppository. Led by Dr Adrian Vella, Mayo Clinic; Rochester, MN, the study is being conducted to provide data to support future clinical investigations of an oral drug (capsule) for the treatment of T2DM.

Infant obesity risk factors identified

Infants stand a greater risk of becoming obese later in childhood if they have a high birth weight, rapid weight gain, or an overweight mother who smoked during pregnancy, according to a new systematic review of childhood risk factors.

Hyularonic acid at the gastroesophageal junction

Endoscopic Injection of Hyaluronic Acid at the Gastro Esophageal Junction as an adjuvant to obesity treatments. An ongoing clinical trial.

In 2012, the treatment of morbid obesity entails several surgical procedures, most of them being performed laparoscopically. In order to gain wider acceptance, research for non-invasive techniques is mandatory in this field. The protocol we introduce here has compared a simple and cheap injection device to a bariatric technique, the intra-gastric balloon.

Studies reinforce benefits of EndoBarrier

Results from a pair of studies into GI Dynamics’ EndoBarrier gastrointestinal liner were presented at the 20th United European Gastroenterology Week, describing the device’s influence on hormones affecting satiety and blood sugar control, and suggesting that it can be effectively re-implanted after its initial insertion period, extending its clinical benefits.

Intra-abdominal fat is risk factor for metabolic syndrome

A six-year study has found that using CT scans to measure intra-abdominal fat area (IAFA) is an effective predictor of the later development of the symptoms of metabolic syndrome in healthy Japanese adults, even in individuals with a BMI under 25.

Refugees face double burden of obesity and malnutrition

25% of Algerian refugee households suffer from both obesity and malnutrition - are aid efforts taking the wrong approach?

Subscribe to RSS - study